Healthpeak Properties, Inc. (DOC) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 10YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 10Y.
- Score
- 8/100
- 10Y CAGR
- 3.8%
- Median YoY
- 5.5%
- YoY volatility
- σ 30.6pp· choppy
- Quarters ≥ 20%
- 5 of 39
- Negative quarters
- 13
- Valuation vs own 10Y history
- P/S 4.9x · 10Y median 6.9x · 17th percentile · as of Aug 19, 2026
How this score is computed
- Quarters at or above 20%: 5 of 39 → 5.1 of 40 pts
- Steadiness (typical swing 30.6pp) → 3.1 of 25 pts
- Pace (median 5.5% YoY) → 0 of 20 pts
- Latest quarter (11.1% YoY) → 0 of 15 pts
- Score: 8 of 100
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Across metrics · 10Y
| Metric | 10Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 3.8% | 5.5% | 30.6pp | 5 of 39 | 13 |
| EPSEPS | — | 40.7% | 508.3pp | 16 of 30 | 13 |
| Op cash flowOperating cash flow | 0.2% | 1.4% | 24.0pp | 7 of 40 | 17 |
| EBITDAEBITDA | 2.7% | 2.7% | 15.9pp | 7 of 39 | 16 |
| FCFFree cash flow | 0.2% | 1.8% | 24.2pp | 7 of 40 | 16 |
Reported figures over 10Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: DOC on the compounders surface · All compounders, ranked